Showing 2,794 results

Filters Content type: News, Editors' picks, About HIV Topic: PrEP

Pre-exposure prophylaxis involves people who do not have HIV taking antiretroviral drugs when they are at risk of exposure to HIV in order to prevent infection. The drugs are usually taken as pills (oral PrEP).

PrEP

European Medicines Agency issues guidance on prevention of HIV transmission for public consultation

Editor's pick
European Medicines Agency
15 March 2012
Vaginal rings & topical PrEP

Tenofovir rectal microbicide safe; may have direct effect on tissues as well as virus

News
7 March 2012
Injectable & long-acting PrEP

Once-a-month HIV drug maintains good levels for prevention; few side-effects so far

News
7 March 2012
PrEP science

Four doses of PrEP a week may be enough to protect

News
6 March 2012
PrEP science

A tale of two trials: how adherence is everything in PrEP

News
6 March 2012
PrEP science

PrEP needs more study before being provided, UK physicians conclude

News
1 March 2012
Pregnancy and vertical transmission

Africa: Nipple Device Could Deliver Drugs to Babies

Editor's pick
AllAfrica
28 February 2012
PrEP science

Australian gay men cautious about PrEP; most in need are the most interested

News
17 February 2012
Women

In Conversation with Nomita Chandhiok: Exploring the ‘tool box’ of HIV prevention strategies

Editor's pick
Mapping Pathways
14 February 2012
PrEP

Gilead: FDA Fast Tracks Review Of HIV Drug Truvada

Editor's pick
Wall Street Journal
14 February 2012
Vaginal rings & topical PrEP

Africa: No Time to 'Give Up' on HIV-Fighting Gel

Editor's pick
All Africa
3 February 2012
PrEP science

For study participants, PrEP was an opportunity to save their relationship

News
30 January 2012
Vaginal rings & topical PrEP

Developing a New Weapon Against HIV

Editor's pick
Boston University Today
30 January 2012
Contraception

Hormonal contraception and HIV risk: no increased risk in South African cohort

News
26 January 2012
PrEP

Open Letter to FDA Urging Immediate Review of PrEP

Editor's pick
Mapping Pathways
25 January 2012
PrEP

Gilead not immune to concern over Truvada's wider HIV use

Editor's pick
Financial Times
24 January 2012
PrEP

Launch of first pre-HIV exposure prevention trial for gay men in Europe

Editor's pick
ANRS press release
11 January 2012
Pharmaceutical industry

Gilead's New HIV Drug Pipeline: What You Need To Know For 2012

Editor's pick
Seeking Alpha
20 December 2011
PrEP

US to rule on preventive use of HIV drug

Editor's pick
Financial Times
16 December 2011
PrEP

Gilead Seeks FDA Approval For Truvada In Reducing HIV Risk In Uninfected Adults

Editor's pick
RTT News
15 December 2011
PrEP

HIV Researcher Dr. Robert Grant named Time "Person of the Year"

Editor's pick
Time
15 December 2011
Adherence

In Combatting AIDS, Beware Methods That Depend on Human Discipline

Editor's pick
Bloomberg (editorial)
14 December 2011
PrEP

Truvada Drug Levels in Vaginal and Rectal Tissue Offer Clues to HIV PrEP Puzzle

Editor's pick
HIVandHepatitis.com
12 December 2011
Circumcision

Focus: Halting HIV/AIDS Epidemics

Editor's pick
Science
12 December 2011